CHMP recommends eight new drugs for approval – one cancer drug rejected

The expert panel at the EMA recommended eight new drugs for approval at its meeting in June, and backed extensions of therapeutic indication for six existing treatments.
Photo: PIROSCHKA VAN DE WOUW/REUTERS / X06750
Photo: PIROSCHKA VAN DE WOUW/REUTERS / X06750
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY CATHERINE BRETT AND NIELSINE NIELSEN

European practitioners will gain new methods for treatment after the June meeting of the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) where the panel recommended several novel drug candidates and new indications for existing drugs.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading